Research to Prevent Blindness (RPB), the leading eye research foundation, is providing $500,000 to accelerate the development of treatments for Retinitis Pigmentosa.
Research to Prevent Blindness (RPB), the leading eye research foundation, is doubling its annual, targeted support of amblyopia research and honoring an esteemed donor, the late Diane Disney Miller
With the approval of 33 new grants to individual scientists and 24 grants to departments of ophthalmology, Research to Prevent Blindness (RPB), the leading foundation supporting eye research, has completed its final round of grant making for 2014.
Research to Prevent Blindness (RPB), the leading eye research foundation, is partnering with the International Retinal Research Foundation (IRRF) to advance knowledge about age-related macular degeneration through novel stem cell research.
Research to Prevent Blindness, the leading eye research foundation, is rolling out a new category of grants designed to foster collaboration between scientists working within departments of ophthalmology and those in complementary fields.
Research to Prevent Blindness (RPB), the leading nonprofit driver of research toward cures and treatments for all blinding disorders, is co-sponsoring a major Institute of Medicine (IOM) study entitled “Public Health Approaches to Reduce Vision Impairment and Promote Eye Health.”
The Research to Prevent Blindness Mildred Krahmer Sanders and William Clifford Sanders Laboratory for Vision Research opened for investigations at the University of Florida, Gainesville, following a national competition to house the facility.
$1.2 million initiative will ask leading scientists to address complex aspects of degraded visual processing with the goal of expanding key knowledge, developing new treatment approaches, and generating technology solutions to enhance vision for those with some remaining sight.
"It's not everyday that one newly discovers parts of the human body," says Roy S. Chuck, MD, PhD, Chairman Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine.
RPB-supported researchers have made a significant discovery that might lead to the delay or prevention of the most common cause of blindness in the elderly: age-related macular degeneration (AMD). Patients who take the drug L-DOPA (for Parkinson Disease, Restless Legs or other movement disorders) are significantly less likely to develop AMD and, if they do, it is at a significantly later age.
RPB Career Development Award recipient Gregory W. Schwartz, PhD, Northwestern University Feinberg School of Medicine has published a finding that opens the door to improving retinal prosthetic devices, targeting treatments to restore damaged retinal circuits, and improving early detection of retinal diseases.
Researchers believe that adults whose eyes are slow to adjust to the dark have a greater risk of developing age-related macular degeneration.
As medical professionals search for new ways to personalize diagnosis and treatment of disease, RPB-supported researchers at the University of Iowa have already put into practice what may be the next big step in precision medicine: personalized proteomics.
RPB President Brian F. Hofland will present an overview of investigations conducted by leaders in the fields of retinal imaging, early disease detection, and photoreceptor regeneration and transplantation. The RPB featured scientists will be present for Q&A.
Separate awards will fund research on the brain's roll in a compromised visual system and on technology to make daily tasks easier for those with vision loss.
The $1.4 million, two-pronged initiative involves funding partnerships with Lions Clubs International Foundation (LCIF), Reader’s Digest Partners for Sight Foundation (RDPFS), and our newest partner, Consumer Technology Association™ Foundation (CTAF).
Separate awards will fund research on the brain's roll in a compromised visual system and on technology to make daily tasks easier for those with vision loss.
The $1.4 million, two-pronged initiative involves funding partnerships with Lions Clubs International Foundation (LCIF), Reader’s Digest Partners for Sight Foundation (RDPFS), and our newest partner, Consumer Technology Association™ Foundation (CTAF).
Researchers at Washington University School of Medicine in St. Louis published a study that shows that genetic material from the Zika virus has been found in tears. The study, fast-tracked for publication in Cell Reports, was conducted in mice, thereby creating an animal model for studying transmission and treatment of this alarming virus. The study, published September 6, 2016, also confirms that the Zika virus can lead to cell death in the eyes. Research to Prevent Blindness, located in New York, provided funding for this study.
"Vision impairment remains notably absent from many population health agendas and community programs,” say the authors of a new report, "Making Eye Health a Population Health Imperative: Vision for Tomorrow," from The National Academies of Sciences, Engineering, and Medicine.
A common pathway involved in photoreceptor death has been identified in retinitis pigmentosa, advanced dry age-related macular degeneration and other retinal diseases, with early evidence of a possible halt to vision loss related to treatment of the pathway.
RPB-supported vision researchers at Washington University School of Medicine in St. Louis have contributed key data to a new study that identifies a natural compound that slows typical signs of aging in mice. The study, published today in Cell Metabolism, shows that older mice drinking water supplemented with NMN (nicotinamide mononucleotide) resembled younger mice in measures of metabolism and energy production.
Research to Prevent Blindness (RPB) awarded 27 grants totaling $5.4 million during its Fall 2016 grant cycle.
Scientists at the Wayne State University School of Medicine Department of Ophthalmology at the Kresge Eye Institute have shown that the Zika virus can replicate in the eye’s retinal cells, causing severe tissue damage and even blindness. The research is supported in part by Research to Prevent Blindness.
With deep sorrow, Research to Prevent Blindness (RPB) announces the passing of John I. Bloomberg (1936 – 2017), who served on the RPB Board of Trustees from 2007 to 2017.
On April 24, Research to Prevent Blindness (RPB) and more than 30 other organizations convened in Washington DC for "Vision Research Funding Partnership IV: Shaping Eye Health in America."
On May 4th, RPB-supported researchers at Washington University School of Medicine in St. Louis published a study identifying a biomarker that could help to predict glaucoma damage before vision loss.
Research to Prevent Blindness (RPB) is proud to lend its support to the vision community and its fellow coalition partners in naming July as Dry Eye Awareness Month, with the goal of enhancing education and communication about this condition. The awareness month coincides with the July publication of the Tear Film & Ocular Surface Society's (TFOS) Dry Eye Workshop II (TFOS DEWS II™) Report in The Ocular Surface journal.
RPB-supported researchers at the University of Illinois at Chicago have identified an enzyme present in the cornea that triggers inflammation during and even after a herpes virus infection has cleared. Their results are published in the journal Cell Reports.
Macular degeneration is the leading cause of vision loss in older adults, but scientists have long struggled to study and replicate key elements of the disease in the lab.
Researchers at Columbia University Medical Center utilized their Research to Prevent Blindness (RPB) grants to make progress in characterizing the genetic and physiologic components of Usher syndrome—the most common cause of deaf-blindness.
Research to Prevent Blindness-supported researchers in New York (at Columbia University and University of Rochester) made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
Research to Prevent Blindness and the American Academy of Ophthalmology today announced that they have created a new category of grant to support researchers who want to use the Academy’s IRIS® Registry database to conduct population-based studies in ophthalmology and blindness prevention.
RPB-supported researchers and physicians at the University of Southern California (USC) Roski Eye Institute have collaborated with other California institutions to show that a stem cell-based retinal implant is feasible for use in people with advanced dry age-related macular degeneration (AMD)
Research to Prevent Blindness has opened a new round of grants available to researchers across the country. This new round of grants significantly expands the pool of applicants who are eligible, by making a number of individual researcher awards available to researchers at all U.S. academic medical centers.
The vision community and its coalition partners refocus education and communications in 2018 around July as Dry Eye Awareness Month. Following the landmark publication of the Tear Film & Ocular Surface Society’s Dry Eye Workshop II, dry eye experts return to Congress and expound upon the Report’s impact in clinical practice and research.
The American Academy of Ophthalmology and Research to Prevent Blindness today announced the first recipients of the RPB/AAO Award for IRIS® Registry Research. The grant supports researchers who want to conduct population-based studies in ophthalmology and blindness prevention.
Jayakrishna Ambati, MD, has been selected as the 2018 RPB David F. Weeks Award for Outstanding AMD Research (Weeks Award).
Research to Prevent Blindness (RPB) and Lions Club International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.
Research to Prevent Blindness (RPB) announces the 30th anniversary of one of its flagship grant programs: the RPB Career Development Award (CDA).
Research to Prevent Blindness, with its partners, the American Macular Degeneration Foundation (AMDF) and the International Retinal Research Foundation (IRRF), has awarded four grants aimed at stimulating and supporting new lines of research targeting age-related macular degeneration (AMD).
Today, the vision community and its coalition partners announced awareness and educational activities in July 2019 around the annual recognition of Dry Eye Awareness Month.
The American Academy of Ophthalmology and Research to Prevent Blindness today announced this year’s recipients of the RPB/AAO Award for IRIS® Registry Research, who are conducting big data research in ophthalmology and blindness prevention.
Christine Curcio, PhD, has been selected as the 2019 RPB David F. Weeks Award for Outstanding AMD Research (Weeks Award). The Weeks Award, funded through the generosity of Research to Prevent Blindness (RPB), an anonymous donor, and the Association of University Professors of Ophthalmology (AUPO), annually recognizes and celebrates an excellent researcher focused on age-related macular degeneration (AMD).
Research to Prevent Blindness (RPB) is pleased to announce that RPB Stein Innovation Awardee Gregg Semenza, MD, PhD, at Johns Hopkins University School of Medicine, has been named a winner of the 2019 Nobel Prize in Medicine.
Research to Prevent Blindness (RPB) celebrates the 60th anniversary of its incorporation. Watch the new video about its many sight-saving accomplishments over the past six decades.
Research to Prevent Blindness and the Allergan Foundation announce new grants to increase funding for innovative research from early-career vision scientists.
Research to Prevent Blindness announces exciting changes to its flagship grant, the RPB Career Development Award, by increasing both the amount of funding and the number of awards funded.
David Williams, PhD, has been selected as the 2021 RPB David F. Weeks Award for Outstanding Vision Research. The Weeks Award, funded through the generosity of Research to Prevent Blindness, an anonymous donor, and the Association of University Professors of Ophthalmology, annually recognizes and celebrates an excellent vision researcher.
The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit of glaucoma research. The TGF (sponsored by Patricia Hill) / RPB Fellowships in Glaucoma provide one-year, $10,000 fellowships focused on substantive glaucoma research.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right